Thoracoscopic pneumonectomy
Conditions
Interventions
Experimental group:PCIA: lidocaine 1.5mg/kg+flurbiprofen axetil 200mg+0.9% NS to 300ml
Control group:PCIA: sufentanil 2ug/kg+flurbiprofen axetil 200mg+0.9% NS To 300ml
Sponsors
Gansu Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-65 2.BMI 18-28 kg/m2 3.ASA classification I-? 4.Clear awareness, basic reading and understanding ability, basically normal vision and hearing, willing to participate in the study. 5.Being able to understand and sign the informed consent form, and cooperate in completing the intervention and evaluation
Exclusion criteria
Exclusion criteria: 1.People who are allergic to the drugs used in this study 2.Complicated with serious cardiovascular disease, liver or kidney dysfunction 3.Experience hyperalgesia or have a history of chronic postoperative pain 4.Have a history of drug or alcohol abuse 5.People with mental illness 6.Patients with peptic ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative analgesia effect; | — |
Countries
China
Contacts
Public ContactYan wenjun
Gansu Provincial People's Hospital
Outcome results
None listed